In the complex world of intellectual property and pharmaceutical development, understanding the intricacies of patent term extension (PTE) is crucial […]
Companies developing a new drug product, even if it is not an NCE, should explore ways to increase the likelihood of obtaining and maximizing PTE This is a guest post…
The post Patent Term Extension for Drugs not Limited to new Chemical Entities appear…
Patent Term Extension for Drugs not Limited to new Chemical Entities Read Post »
The value of obtaining multiple PTEs on different patents could incentivize innovators to revise their clinical development programs This is a guest post from Nicole Stakleff and Kyle Dolinsky in…
The post How to Obtain Multiple Patent Term Extensions …
How to Obtain Multiple Patent Term Extensions for a Single Product Read Post »
The total cost of developing, manufacturing, testing, and marketing a generic drug in India costs just 20% to 40% of the expenses in the West. A Glimpse of the API…
The post How to find a reputable API supplier appeared first on DrugPatentWatch – Make …
The financial risks of being found liable for patent infringement are astronomically high Developing a strategy for the development, production and the final launch of a new drug is a…
The post How to Conduct a Drug Patent FTO Search appeared first on …
There is a strong incentive to find out new opportunities for the discovery of new drugs Annual sales in the pharmaceutical sector have been increasing in the double-digit range for…
The post Using drug patent information to synthesize drugs appeared f…
Using drug patent information to synthesize drugs Read Post »
What is Data Exclusivity? In 1984, the USA was the first country to give legal sanctity to data exclusivity via the Hatch-Waxman Act. Under this new legislation five years of…
The post Data Exclusivity: Is there a happy medium? appeared first on DrugPa…
Drug prices are mysterious and unpredictable for many consumers With the average person’s out-of-pocket expense for a drug determined by several interdependent factors, planning for care is harder, and trying…
The post Deconstructing Drug Pricing Strat…
Deconstructing Drug Pricing Strategy for Big Pharma Read Post »
Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are designed to be less costly alternatives to branded biologic drugs.…
The post Exploring Biosimilars as a Drug Pa…
Drug repositioning offers an alternative path to drug development Researchers at the US drug group Pfizer’s Sandwich research center while working on an angina treatment found a compound by the…
The post Using clinical trial information to forecast fut…
Using clinical trial information to forecast future therapeutic indications Read Post »
Get new actionable insights and updates from BiotechBlog
